Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Royalty Pharma PLC (NASDAQ:RPRX) Given Consensus Rating of 'Buy' by Analysts
Shares of Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) have been assigned a consensus rating of 'Buy' from the seven brokerages that are currently covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock…
VIRGINIA RETIREMENT SYSTEMS ET Al Increases Stock Holdings in BridgeBio Pharma, Inc. $BBIO
VIRGINIA RETIREMENT SYSTEMS ET Al raised its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 146.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 25,850 shares…
Buying What Markets Ignore
Motilal Oswal Mutual Fund has entered the contra fund category with an NFO in May, adding to a relatively under-populated segment that currently houses only three schemes: SBI Contra, Invesco India Contra and Kotak India EQ Contra Fund. The launch…
KIA crosses 400 million passenger milestone in April
Kempegowda International Airport (KIA), Bengaluru, crosses the 400 million passenger milestone since its Airport Opening Day (AOD), in April, 2026. The airport also registered a strong growth in the financial year 2025-26, driven by international…
SRF: On The Road to Recovery
SRF reported its Q4FY26 results in early May and provided a strong outlook. We had earlier recommended a hold on the stock in August 2025 because valuations were elevated at 44 times one-year forward earnings even when factoring for expectations of…
Opinion | How Low Can America Go?
For many doctors like me, Donald G. McNeil Jr.'s byline will always inspire respect. A New York Times (NYT) reporter since the 1970s, he first earned his medical stripes in the 1990s as a foreign correspondent covering HIV/AIDS in South Africa.
Teva Pharmaceutical Industries Ltd. $TEVA Shares Purchased by Bessemer Group Inc.
Bessemer Group Inc. lifted its position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 861,152.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The…
Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever
Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it can live up to the hype. Icotyde went to market after the Food and Drug Administration approved it in mid-March for…
Heron Bay Doubles Down on Vontier, Buying 1.37 Million Shares
According to a Securities and Exchange Commission (SEC) filing dated May 13, 2026, Heron Bay Capital Management acquired an additional 1,370,006 shares of Vontier (VNT 2.40%), during the first quarter. The estimated transaction value is $52.76…
MFs Cut Their Cash Cushion
Active equity mutual funds have sharply cut their cash buffers over the past year. Cash holdings fell from ₹3 lakh crore in April 2025 to ₹1.68 lakh crore in April 2026, while cash as a share of active equity fund AUM declined from…
Lawood & Co. Takes Position in AbbVie Inc. $ABBV
Lawood & Co. bought a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 12,555 shares of the company's…
AbbVie Inc. $ABBV Shares Acquired by Lockheed Martin Investment Management Co.
Lockheed Martin Investment Management Co. grew its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 12.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned…
Commerzbank Aktiengesellschaft FI Sells 10,690 Shares of AbbVie Inc. $ABBV
Commerzbank Aktiengesellschaft FI lessened its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 11.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 79,412 shares of the company's…
AustralianSuper Pty Ltd Trims Stock Holdings in The Goldman Sachs Group, Inc. $GS
AustralianSuper Pty Ltd trimmed its holdings in The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 83.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor…
The Goldman Sachs Group, Inc. $GS Shares Acquired by Stephens Inc. AR
Stephens Inc. AR increased its position in shares of The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 11.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission…
Receive a Daily briefing on Pharma Industry News
Get Started